Skip to main content
Logo

Search form

  • Home
  • Who we are
    • About Synnovis
    • Our people
    • Our services
    • Innovation
    • Quality
  • What we do
    • Departments and laboratories
    • Phlebotomy training
    • Primary Care Information Centre
    • Swiftqueue
  • Tests and results
    • Test index
    • Tests A-Z
    • Test information
    • UKAS Accreditation
  • Service Users
    • Secondary Care NHS Trusts
    • Private Users
    • Primary Care Information Centre
  • Resources
    • News and press
    • Articles and papers
    • About the Hub
    • Synnovis Policies, User Guides and Documents
    • Transformation
  • Join us
    • Your career
    • Working with us
    • Career pathways
    • Current vacancies
    • Training and development
  • Contact us
    • Locations
    • Key contacts
    • Commercial Testing & Partnership Enquiries
    • Customer service
    • Cyber Attack Information Centre
  • Welcome, Sign in or Register
Menu

Liquid Swabs

Liquid swabs training videos

See here for our collection of liquid swabs training videos.

MRSA Single Swab

 

 

MRSA Triple Swab

 

 

Liquid Swabs FAQS

Below are some FAQS on Liquid Swabs to provide information around timelines, training and other key information.

TIMELINE AND ROLL-OUT

When will the transition take place?

The rollout of swabs and tubes will happen simultaneously but is scheduled in phases, aligning with the broader transformation migration plan. Specific go-live dates will be communicated to each site in advance. Phased rollout is expected to begin late October, starting with primary care, followed by the Trusts.

Where has this rollout been successfully implemented elsewhere?

This roll out is happening around the world and the closest to your locations would be South West London Pathology (SWLP), which completed the Σ-TRANSWAB MRSA change earlier this year and is now changing to the Wound Swabs (Σ-TRANSWAB®)

SWAB TECHNOLOGY AND EFFICIENCY

How does the new liquid swab improve efficiency compared to gel swabs?

Liquid swabs allow for automated processing, reducing manual handling, increasing testing speed and improving accuracy in microbiology diagnostics.

What is the main handling difference between the current swab and the new swab?

The current TRANSWAB® is a gel and the newer Σ-TRANSWAB® is a liquid swab, so contains no agar. The other main difference for MRSA testing is the current triple MRSA process will move to a 3 in 1 sample process.

STOCK MANAGEMENT AND TRANSITION

Will existing stock be replaced immediately?

A phased approach will be taken to ensure a smooth transition. We are working with Trust procurement teams to ensure robust arrangements are in place throughout. Recommendation is removal of the gel ordering when stocks have been depleted.

Will a manual processing option be available for older swabs / urine bottles during the initial transition period?

Yes, gel swabs and old urine bottles will still be processed for a limited time post-rollout to support the transition period.

Will gel swabs/urine bottles sent in error still be processed during the transition?

Yes – see above

SAMPLE COLLECTION AND HANDLING

What is the main handling difference between the current swab and the new swab that users will have to adapt to?

The main difference is that the current triple MRSA process will move to a 3 in 1 sample process, which is quicker and more precise. It works by a) swabbing the groin and swishing in the liquid, before swab is discarded; b) swabbing armpit and same as (a); c) nasal swab, put in vial, snap off non-swab end and screw on vial cap, leaving just one swab and sample within. This aligns with industry best practice and it is a process being adopted globally.

Does the order of swab collection matter for MRSA testing?

Yes, the nasal swab must be collected last to prevent cross-contamination. The order of groin and armpit swabs can be flexible.

How should the discarded swabs be disposed of?

Use a sharps bin or other designated biohazard disposal.

Is there a risk of spillage during swab handling? What would be the impact?

There may be a risk of spillage, as this is a liquid rather than a gel. However, there are no hazardous materials present in the swab. If there is a spill, we would suggest you use a new swab and vial to ensure the correct results. Further handling information will be available during training.

What happens if the liquid in the swab vial is spilled before processing?

If the liquid is spilled, the test cannot be conducted, as the liquid medium is essential for processing the sample.

What are the risks associated with the new swab method?

There are no new risks, other than if the red swabs used for the MRSA testing are left in the Σ-TRANSWAB® Liquid when sent to the labs, as the test would be void. This would only happen if you cut the swabs to fit them into the tube. Only the white (nasal) swab should be left in the tube.

What precautions should be taken when collecting samples using liquid swabs?

The same precautions for the gel and Σ-TRANSWAB® Liquid swabs should be taken (i.e. wear gloves and dispose of the waste safely).

TRAINING AND SUPPORT

What training will staff receive and when?

Training sessions will be planned weeks ahead of each site's rollout, ensuring sufficient time for staff education and practice. Training will cover correct collection procedures for the new swabs and best practices for handling liquid swabs. Training videos and materials will be provided (including visuals), accessible via a dedicated page on the Synnovis website, as well as on-site (ward level) training.. The Supplier will train Practice Development Nurse Team (PDNs), who will then cascade training to nursing staff across Trust sites and in the community.
 

What support will be available during the transition?

The suppliers Medical Wire (MWE) have a sales team available to train at ward level, supported by the trusts, as well as training videos that are in production.

What is the plan for training staff across multiple sites?

Training will be delivered through a combination of on-site sessions, webinars and recorded instructional materials to ensure accessibility across all sites.

Can training sessions be modified based on user and site requirements?

Yes, each trust will work with the supplier to tailor training approaches based on site needs, workforce size and logistical constraints.

Last updated: 24/09/2025

eMail alerts and news

Sign up with Viapath to receive our newsletter and hear about our scientific events.
Privacy policy

Follow us

Twitter LinkedIn RSS

Site details

  • Privacy policy
  • Cookies
  • Terms of use
  • Accessibility
  • Sitemap
  • Feedback

Working with our NHS service partners to set the standard for the future of pathology

 

Gyu's and St Thomas'
King's College Hospital

 

Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. 

Copyright 2014-2025 Synnovis Group LLP. Synnovis, the Synnovis logo and Nutris are registered trademarks of Synnovis Group LLP.

Home
Who we are
  • About Synnovis
  • Our people
  • Our services
  • Innovation
  • Quality
What we do
  • Departments and laboratories
  • Phlebotomy training
  • Primary Care Information Centre
  • Swiftqueue
Our tests
  • Test index
  • Tests A-Z
  • Test information
  • UKAS Accreditation
Service users
News and media
  • News and press
  • Articles and papers
  • About the Hub
  • Synnovis Policies, User Guides and Documents
  • Transformation
Careers
  • Your career
  • Working with us
  • Career pathways
  • Current vacancies
  • Training and development
Contact us
  • Locations
  • Key contacts
  • Commercial Testing & Partnership Enquiries
  • Customer service
  • Cyber Attack Information Centre
Close menu